22,900 Shares in Alignment Healthcare, Inc. (NASDAQ:ALHC) Bought by Two Sigma Investments LP

Two Sigma Investments LP purchased a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 22,900 shares of the company's stock, valued at approximately $258,000.

Other hedge funds also recently bought and sold shares of the company. RiverPark Advisors LLC acquired a new stake in Alignment Healthcare in the 4th quarter valued at about $106,000. Tower Research Capital LLC TRC raised its holdings in Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after acquiring an additional 6,286 shares during the last quarter. Aigen Investment Management LP acquired a new stake in Alignment Healthcare in the 4th quarter valued at about $129,000. AlphaQuest LLC acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth approximately $132,000. Finally, Dark Forest Capital Management LP acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth approximately $150,000. Institutional investors and hedge funds own 86.19% of the company's stock.

Insider Transactions at Alignment Healthcare

In related news, insider Andreas P. Wagner sold 7,632 shares of Alignment Healthcare stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $16.40, for a total transaction of $125,164.80. Following the sale, the insider now directly owns 223,474 shares in the company, valued at $3,664,973.60. This trade represents a 3.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of Alignment Healthcare stock in a transaction on Monday, May 19th. The stock was sold at an average price of $15.28, for a total transaction of $259,760,000.00. Following the sale, the director now owns 44,302,175 shares in the company, valued at $676,937,234. This represents a 27.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 17,857,663 shares of company stock valued at $274,376,217. Insiders own 7.00% of the company's stock.

Alignment Healthcare Stock Down 0.9%

ALHC stock traded down $0.14 during midday trading on Friday, hitting $14.94. The company's stock had a trading volume of 1,581,551 shares, compared to its average volume of 2,044,923. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a 52-week low of $7.05 and a 52-week high of $21.06. The firm has a market capitalization of $2.96 billion, a P/E ratio of -19.40 and a beta of 1.22. The firm has a 50-day simple moving average of $16.37 and a 200-day simple moving average of $14.90.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The company had revenue of $926.93 million during the quarter, compared to analysts' expectations of $889.83 million. During the same quarter last year, the company posted ($0.25) EPS. The firm's revenue was up 47.5% compared to the same quarter last year. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Bank of America raised their price target on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a report on Tuesday, March 4th. Barclays raised their price target on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a report on Friday, February 28th. Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Piper Sandler lifted their target price on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a report on Tuesday, March 4th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a report on Thursday, March 6th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $17.17.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.